PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryNov 12, 2014	Integra LifeSciences Introduces Integra(R) Pocket Strip and Integra(R) Shaped Strip DBM Implants Company's First DBM Implants Specifically Designed for Posterior Lumbar Spine Fusion Procedures	View HTML Integra LifeSciences Introduces Integra(R) Pocket Strip and Integra(R) Shaped Strip DBM Implants 12 KB
Toggle SummaryNov 3, 2014	Integra LifeSciences Reports Third Quarter 2014 Financial Results Revenue Increased 7.7% to $229.7 Million GAAP EPS was $0.30 Adjusted EPS Increased 16% to $0.76 Operating Cash Flow was $31.1 Million PLAINSBORO, N.J., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the third quarter	View HTML Integra LifeSciences Reports Third Quarter 2014 Financial Results 23.5 KB
Toggle SummaryNov 3, 2014	Integra LifeSciences Announces Strategic Portfolio Alignment and Plans to Create Stand-Alone Spine Business as a Separate Public Company Plans to Spin Off Spine Business to Create SeaSpine, a New Publicly Traded Company, By Means of Tax-Free Distribution to Integra Shareholders Both Companies Will be Leaders in Providing Regenerative Technologies Integra to Operate as Two Global Divisions in 2015 Upon Completion of the Spin-Off:	View HTML Integra LifeSciences Announces Strategic Portfolio Alignment and Plans to Create Stand-Alone Spine Business as a Separate Public Company 23.5 KB
Toggle SummaryOct 27, 2014	Integra LifeSciences Completes the Acquisition of MicroFrance and Xomed Manual ENT and Laparoscopy Instrumentation Lines From Medtronic PLAINSBORO, N.J., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has completed the acquisition of the MicroFrance and Xomed manual ear, nose and throat (ENT) and laparoscopy instrumentation lines from Medtronic.	View HTML Integra LifeSciences Completes the Acquisition of MicroFrance and Xomed Manual ENT and Laparoscopy Instrumentation Lines From Medtronic 10.6 KB
Toggle SummaryOct 9, 2014	Integra LifeSciences to Host Its Third Quarter 2014 Earnings Results Conference Call on November 3, 2014 PLAINSBORO, N.J., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its third quarter 2014 financial results on Monday, November 3, 2014. The company has scheduled a conference call for 4:30 PM ET the same day to discuss the results.	View HTML Integra LifeSciences to Host Its Third Quarter 2014 Earnings Results Conference Call on November 3, 2014 10 KB
Toggle SummarySep 18, 2014	Integra LifeSciences Announces Full Market Release for the Integra(R) Freedom Wrist Arthroplasty System PLAINSBORO, N.J., Sept. 18, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the full commercial release of the Integra® Freedom Wrist Arthroplasty System in the United States. The system, which is used in the treatment of wrist arthritis, has been	View HTML Integra LifeSciences Announces Full Market Release for the Integra(R) Freedom Wrist Arthroplasty System 12 KB
Toggle SummarySep 17, 2014	Integra LifeSciences to Acquire Medtronic's MicroFrance and Xomed Manual ENT and Laparoscopy Instrumentation Lines PLAINSBORO, N.J., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) and Medtronic, Inc. today announced an agreement in which Integra will acquire Medtronic's MicroFrance and Xomed manual ENT and laparoscopy instrumentation lines for approximately $60	View HTML Integra LifeSciences to Acquire Medtronic's MicroFrance and Xomed Manual ENT and Laparoscopy Instrumentation Lines 12 KB
Toggle SummarySep 2, 2014	Integra LifeSciences Announces Changes Within Its Orthopedics and Tissue Technologies Business PLAINSBORO, N.J., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has made changes to the leadership of its Orthopedics and Tissue Technologies business. The new organization enables Integra to use its resources more efficiently in	View HTML Integra LifeSciences Announces Changes Within Its Orthopedics and Tissue Technologies Business 12.1 KB
Toggle SummaryAug 21, 2014	Integra LifeSciences to Participate in the Morgan Stanley Global Healthcare Conference in September PLAINSBORO, N.J., Aug. 21, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conferences next month: - At 10:35AM ET on Tuesday, September 9, 2014, Mr. Peter Arduini, Integra's President and Chief Executive	View HTML Integra LifeSciences to Participate in the Morgan Stanley Global Healthcare Conference in September 10.1 KB
Toggle SummaryAug 5, 2014	Integra LifeSciences Reports Second Quarter 2014 Financial Results Revenue Increased 12.6% to a Record of $231 million Adjusted Diluted EPS Increased by 28% Free Cash Flow Increased by $17.7 million PLAINSBORO, N.J., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the second quarter	View HTML Integra LifeSciences Reports Second Quarter 2014 Financial Results 52.5 KB
Toggle SummaryAug 5, 2014	Integra LifeSciences Announces Completion of Its Multicenter Clinical Trial for the Treatment of Diabetic Foot Ulcers PLAINSBORO, N.J., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has completed Its multicenter clinical trial evaluating the safety and effectiveness of INTEGRA® Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers	View HTML Integra LifeSciences Announces Completion of Its Multicenter Clinical Trial for the Treatment of Diabetic Foot Ulcers 13.8 KB
Toggle SummaryJul 10, 2014	Integra LifeSciences to Host Its Second Quarter 2014 Earnings Results Conference Call on August 5, 2014 PLAINSBORO, N.J., July 10, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its second quarter 2014 financial results on Tuesday, August 5, 2014. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.	View HTML Integra LifeSciences to Host Its Second Quarter 2014 Earnings Results Conference Call on August 5, 2014 9.7 KB
Toggle SummaryJul 9, 2014	Integra LifeSciences Announces Renewal and Extension of Credit Facility PLAINSBORO, N.J., July 9, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has established new terms under its credit facility, including an increase in the size of the facility and an extended maturity date, with its bank group led by Bank of	View HTML Integra LifeSciences Announces Renewal and Extension of Credit Facility 10.8 KB
Toggle SummaryJun 19, 2014	Integra LifeSciences Celebrates 25th Anniversary PLAINSBORO, N.J., June 19, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a world leader in medical technology, today announced that June 2014 marks the 25 th anniversary of its founding. Twenty-five years ago, Richard Caruso, PhD, currently a member of Integra's	View HTML Integra LifeSciences Celebrates 25th Anniversary 11.7 KB
Toggle SummaryJun 12, 2014	Integra LifeSciences Announces Contract with Premier, Inc. Will Provide Small Bone Orthopedic Implants	View HTML Integra LifeSciences Announces Contract with Premier, Inc. 16.1 KB